The research emphasizes several methodologically comparative questions regarding the treatment of this pathology: Does the stimulation modality offer reductions in AF burden, does it affect inflammatory pathways such as NOX or biomarkers such as TNF-α, and are there specific patient groups who would benefit more? Here, TNF is linked to atrial fibrillation.